What Is L. bulgaricus and How Does It Work?

Lactobacillus bulgaricus is a lactic acid bacterium best known as one of the two organisms required to make yogurt. Its formal name is Lactobacillus delbrueckii subsp. bulgaricus, and its primary job is straightforward: it digests the sugar in milk (lactose) and converts it into lactic acid, which drops the pH, thickens the milk, and creates the tangy flavor people associate with yogurt. But this single species does more than sour milk. It breaks down proteins into smaller peptides, produces compounds that shape aroma and texture, secretes substances that inhibit harmful bacteria, and interacts with the immune system in ways researchers are still mapping out.

A Bacterium Named After Bulgaria

The organism was first isolated in the early 1900s from traditional Bulgarian yogurt. The broader scientific backstory involves Élie Metchnikoff, the Nobel Prize-winning immunologist who championed the idea that consuming beneficial bacteria could counteract harmful gut microbes and extend life. Metchnikoff is considered the father of probiotics, and he popularized the use of beneficial bacteria as a tool to delay the damaging effects of toxic compounds produced by putrefactive gut bacteria.¹ His attention to Bulgarian villagers who ate large quantities of fermented milk put L. bulgaricus on the scientific map and gave the organism its geographic surname.

Taxonomically, it sits within the species Lactobacillus delbrueckii and is classified as a subspecies. Despite the reclassification efforts that have shuffled many lactobacilli into new genera in recent years, L. bulgaricus has kept its place in the Lactobacillus genus. Genome sequencing has revealed that the organism is a specialist: its DNA shows extensive reductive evolution, meaning it has shed genes it no longer needs because milk provides so many ready-made nutrients.² In other words, it has become deeply adapted to a milk environment over centuries of dairy use, and it does that one job exceptionally well.

How It Turns Milk Into Yogurt

L. bulgaricus is classified as a homofermentative lactic acid bacterium, which means that when it digests lactose, the vast majority of what it produces is lactic acid rather than a mix of different fermentation byproducts.³ That acid accumulation is what curdles the milk proteins (caseins), forming the semi-solid gel that gives yogurt its body. The process typically unfolds at warm temperatures, usually between about 40 and 45°C (104–113°F), which is why yogurt makers incubate their product rather than leaving it at room temperature.

Beyond producing acid, L. bulgaricus has a powerful proteolytic system. It breaks down the casein proteins in milk into smaller peptides and free amino acids, which it needs for its own growth.⁴ This protein-chopping activity has a side benefit: some of those peptides are bioactive, meaning they have measurable effects on biological processes like blood-pressure regulation and antioxidant defense.⁵ The casein fraction most readily broken down is beta-casein, which is the most abundant casein in cow’s milk.

The Partnership With Streptococcus thermophilus

Yogurt is not a solo act. Virtually every standard yogurt culture contains both L. bulgaricus and Streptococcus thermophilus, and the two organisms cooperate in a relationship microbiologists call protocooperation. Each one provides something the other needs. L. bulgaricus breaks down milk proteins and releases free amino acids and peptides that S. thermophilus uses for growth. In return, S. thermophilus produces formate, a compound that stimulates L. bulgaricus.⁶

The cooperation goes further than nutrient trading. S. thermophilus can produce glutathione, an antioxidant molecule, and secrete it into the surrounding medium. Research has shown that this exported glutathione helps protect L. bulgaricus against acid stress as the pH drops during fermentation. L. bulgaricus imports the glutathione into its own cells, which improves its growth under acidic conditions.⁷ The result is that both species grow better and ferment milk faster together than either one does alone.

The ratio of the two organisms matters for the final product. When the coculture was tested at an optimized ratio of roughly 19 parts S. thermophilus to 1 part L. bulgaricus, the yogurt showed higher acidification activity, better texture, richer volatile-compound profiles, and more desirable sensory quality than either species produced on its own.⁸ This is why yogurt producers spend time fine-tuning their starter-culture ratios rather than simply dumping both bugs in and hoping for the best.

Flavor and Texture Contributions

The tangy taste of yogurt comes primarily from lactic acid, but the full flavor profile is more nuanced. Mixed fermentations of L. bulgaricus and S. thermophilus regulate genes related to glycolysis in ways that increase pyruvate production, and pyruvate is an important precursor for two key aroma compounds: diacetyl (which gives a buttery note) and acetoin. Depending on the ratio of the two species, yogurt can end up richer in acetaldehyde, which contributes to the “green apple” or fresh yogurt smell, or richer in diacetyl and acetoin.⁹ Acetaldehyde is commonly considered the compound most responsible for what people identify as “yogurt flavor,” and L. bulgaricus is the heavier producer of it compared to S. thermophilus.

Texture is another area where strain selection matters enormously. Some strains of L. bulgaricus produce exopolysaccharides, which are long sugar-chain molecules secreted outside the cell. These exopolysaccharides act as natural thickeners and stabilizers, interacting with the casein network in yogurt to create a smoother, more extensible gel. Yogurt made with exopolysaccharide-producing strains shows less shear thinning, meaning it holds its texture better when stirred or spooned, compared to yogurt made with non-producing strains.¹⁰ For manufacturers, this can reduce or eliminate the need for added stabilizers like gelatin or pectin, which is appealing for “clean label” products.

Does It Survive Digestion?

One of the long-running debates around yogurt cultures is whether L. bulgaricus and S. thermophilus actually survive the harsh acid bath of the stomach and the bile salts of the small intestine. They are not traditionally classified as “probiotic” in the way that species like Lactobacillus rhamnosus GG or Bifidobacterium animalis BB-12 are, because their primary role is fermentation rather than colonizing the gut. Yet the evidence suggests they do survive transit in meaningful numbers.

In a study of 13 healthy volunteers who ate fresh yogurt daily for 12 days, viable L. delbrueckii was recovered from fecal samples in 37 out of 39 collections, at a median concentration of about 72,000 colony-forming units per gram of feces.¹¹ Animal research has corroborated this: in minipigs with intestinal fistulae that allowed direct sampling, living L. bulgaricus cells were found in the terminal ileum at concentrations of roughly a million to ten million per gram of intestinal contents.¹² So while L. bulgaricus does not set up permanent residence in your gut the way some other lactobacilli can, a substantial fraction of the cells you eat in yogurt appear to pass through alive. Whether that transient presence drives clinically meaningful effects is a separate question.

Immune and Anti-Inflammatory Activity

The immune effects of L. bulgaricus are often linked to its exopolysaccharides rather than the living cells themselves. Mouse studies have shown that exopolysaccharides from one particular strain (OLL1073R-1) boosted natural killer cell activity and stimulated interferon-gamma production. Cellular preparations of the bacteria also had a slight effect, but the purified exopolysaccharide fraction was more effective on its own.¹³ Natural killer cells are part of the body’s frontline innate defense against viruses and abnormal cells, so a boost in their activity is potentially useful, though translating mouse results to human health outcomes always requires caution.

Broader work on lactic acid bacteria, including L. bulgaricus strains, has shown that these organisms stimulate macrophages to produce immune-signaling molecules like IL-12 and interferon-gamma, as well as reactive oxygen and nitrogen species. Interestingly, strains whose cell walls were more elastic tended to resist digestion by macrophages more effectively and provoked a stronger activation response.¹⁴ The physical properties of the bacterial cell surface, not just what the bacterium secretes, seem to influence how the immune system responds.

A recent clinical safety and efficacy trial of a specific strain called LB42 found that supplementation was well tolerated with no adverse events, and it significantly improved gastrointestinal symptom scores, sleep quality scores, and lowered fecal calprotectin, a marker of intestinal inflammation.¹⁵ These are encouraging early results, though single-strain findings from individual trials should not be generalized to all L. bulgaricus strains.

Antimicrobial Compounds

Beyond helping the immune system, L. bulgaricus can fight pathogens more directly. Some strains produce bacteriocins, which are small antimicrobial peptides that kill or inhibit the growth of other bacteria. One such compound, bulgaricin BB18, was isolated from a strain found in traditional Bulgarian dairy products and turned out to be a novel bacteriocin with strong activity against Helicobacter pylori, the bacterium responsible for most stomach ulcers.¹⁶ This bulgaricin was heat-stable (surviving autoclave temperatures of 121°C for 15 minutes) and remained active across a wide pH range of 2 to 10.

Another strain, K41, isolated from locally made yogurts, produced a bacteriocin-like substance with extremely strong anti-listerial activity, acting in a bactericidal mode against Listeria monocytogenes.¹⁷ Listeria is a serious food-safety concern, especially in dairy products, so the fact that certain yogurt cultures may help suppress it has practical relevance for food safety. These bacteriocins tend to work best against Gram-positive pathogens; their effectiveness against Gram-negative bacteria is generally limited.

The Limits of the Clinical Evidence

It is worth being honest about where the evidence thins out. While immunological and antimicrobial effects look interesting in lab and animal studies, clinical trials testing L. bulgaricus as a therapy in humans have produced mixed results. A systematic review and meta-analysis looking at L. acidophilus and L. bulgaricus for treating diarrhea found that the treatment group had a diarrhea rate only about 3.5 percentage points lower than the placebo group, a difference the researchers considered of little or no clinical importance.¹⁸

A trial specifically looking at yogurt for preventing antibiotic-associated diarrhea told a similar story. Patients receiving probiotic yogurt (which contained additional probiotic strains beyond the standard yogurt cultures) actually had a slightly higher diarrhea rate of 23% compared to 17.6% in the group drinking plain yogurt with just S. thermophilus and L. bulgaricus, a difference that was not statistically significant.¹⁹ These results suggest that the standard yogurt pair on their own may not be powerful enough to prevent common diarrheal illness in most people. The strain-specific findings for LB42 on gut symptoms and inflammation markers are more promising, but they come from a single trial and need replication.

Regional Diversity and Traditional Fermentation

Not all L. bulgaricus strains are identical. A large population genomics study that sequenced 188 strains isolated from naturally fermented dairy products, plus 19 publicly available genomes, identified four distinct genetic clusters. These clusters correlated with the geographic regions where the samples had been collected.²⁰ This means that yogurt traditions in different parts of the world have, over time, selected for genetically distinguishable populations of the bacterium. The terroir of yogurt, in a loose sense, is real: the strains used in Bulgarian kiselo mlyako are not the same as those in Central Asian kumiss or East African fermented milk.

This diversity matters practically. Different strains vary in how much acid they produce, how fast they ferment, what exopolysaccharides they make, and what flavor compounds they generate. The dairy industry invests considerable effort in screening wild strains from traditional products to find ones with desirable traits for commercial use. Meanwhile, the genetic uniqueness of these traditional strains creates a conservation argument: as industrial starter cultures become standardized worldwide, the genetic diversity that traditional fermentation practices have maintained over centuries is at risk of being lost.

Phage Defense and Industrial Stability

One of the biggest headaches in industrial yogurt production is bacteriophage attack. Phages are viruses that infect and kill bacteria, and a phage outbreak in a yogurt factory can destroy an entire fermentation batch. L. bulgaricus has its own defense: CRISPR-Cas systems, the same molecular machinery that has become famous as a gene-editing tool, originally evolved in bacteria as an immune system against phages.

A genomic survey of 119 L. bulgaricus strains found 123 CRISPR-Cas systems, predominantly of two types. The study also identified over 1,700 prophage fragments embedded in the bacterial genomes, though fewer than 9% were classified as complete prophages, and none carried virulence or antibiotic resistance genes. There was a negative correlation between the number of CRISPR spacers a strain carried and its prophage load, consistent with the idea that a more active CRISPR defense keeps phages at bay.²¹ For the dairy industry, understanding which strains have robust CRISPR defenses helps in selecting starter cultures that will resist phage disruptions during large-scale production.

Beyond Dairy

While L. bulgaricus evolved in a milk environment, it is not permanently confined there. Researchers have successfully used standard yogurt starter cultures containing L. bulgaricus and S. thermophilus to ferment hazelnut milk, producing a plant-based product with a final pH of about 4.95 and measurable lactic acid production.²² The protein and fat content of the plant-based fermented product differs from dairy yogurt, and serum separation (whey-off) tends to be higher, but the basic fermentation works. Similar trials have been done with soy, oat, and coconut milks, which is why many commercial plant-based yogurts use the same bacterial species as dairy yogurt.

An entirely separate application has emerged outside of food: the bacterium’s ability to produce optically pure D-lactic acid makes it a candidate for manufacturing polylactic acid, a biodegradable plastic. Researchers have used metabolic engineering to enhance L. bulgaricus strains for D-lactic acid output, positioning the organism as a potential green-chemistry workhorse.³ The overlap between yogurt fermentation and bioplastics may seem strange, but it is rooted in the same core metabolism: the bacterium eats sugar and makes lactic acid. The question is just what you do with the lactic acid afterward.

Postbiotics and Dead Bacteria That Still Do Things

An emerging area of interest is what happens when L. bulgaricus cells are killed, either by heat treatment or other processing. The field has coined two terms for this. Postbiotics refer to the metabolic byproducts and cell components released by probiotic organisms that have biological activity in the host even without living cells.²³ Para-probiotics refer to the non-viable microbial cells themselves, which can modulate immune responses, reinforce intestinal barrier integrity, and enhance mucosal defense mechanisms through interactions between microbial surface molecules and host immune receptors.²⁴

This is relevant to L. bulgaricus because much of its immunological activity appears to come from its exopolysaccharides and cell-wall components rather than from anything that requires the bacterium to be alive and metabolically active. If dead cells or their fragments can trigger immune activation, the implications for product design are significant: shelf stability becomes easier, cold-chain requirements relax, and dosing becomes more predictable. Heat-treated yogurt products, which contain killed starter cultures, might carry some of the immune-modulating benefits of fresh yogurt even though the bacteria are no longer viable. The research is still early, but it challenges the assumption that only living bacteria confer health benefits.